What Are the Symptoms of Radon Poisoning: None Acutely
“What are the symptoms of radon poisoning?” is the direct question. The direct answer: none acutely. Radon does not cause acute symptoms or “radon poisoning” as a clinical event. It is an odorless, colorless, tasteless radioactive gas. Per the U.S. Surgeon General and EPA, radon is the second-leading cause of lung cancer after smoking — responsible for approximately 21,000 deaths per year in the U.S. — but only after long-term exposure (typically 5 to 25+ year latency). There are no immediate symptoms, signs, or “poisoning event.” If you have acute respiratory concerns, see a physician — those symptoms are not caused by radon.
This guide is the most comprehensive direct answer to the question. It explains why “radon poisoning” is a medical misnomer, walks through the EPA and Surgeon General risk framework, covers what does eventually appear after decades of exposure, and routes the reader to physician care and home testing as the appropriate actions.
This guide summarizes EPA, CDC, U.S. Surgeon General, American Lung Association, NIEHS, NIH, and CDPHE guidance current as of 2026. It is informational, not medical advice; consult a physician for any symptoms and a certified radon professional for home testing and mitigation. For the broader context, see the radon testing guide for Front Range homeowners.
Direct answer: there are no symptoms of radon poisoning
“Radon poisoning” is a phrase searched roughly 100,000 times per month in the U.S. according to keyword tools, but it is not a clinical diagnosis recognized by physicians or by EPA. There is no ICD-10 code for “radon poisoning.” There is no diagnostic test for radon body burden. There are no acute symptoms attributable to radon exposure at residential concentrations.
The closest medically valid diagnosis is “radon-attributable lung cancer,” which is a subset of lung cancer where exposure history points to radon as a probable contributor. This diagnosis applies to established disease, not to recent or current exposure.
Why “poisoning” is the wrong word
Poisoning, in toxicology, refers to chemical or biological agents that cause harm through interaction with body tissues — heavy metals, pesticides, snake venom, carbon monoxide binding hemoglobin. The harm appears within minutes to days at toxic doses and produces measurable symptoms (nausea, vomiting, loss of consciousness, organ failure).
Radon does not work this way. As a noble gas, radon does not chemically interact with body tissues. Inhaled radon is exhaled within seconds. The mechanism of harm is radiological (ionizing alpha radiation from radon decay products in lung tissue) and statistical (cumulative DNA damage over years), not chemical and acute. Calling this “poisoning” creates the false expectation of acute symptoms that radon never produces.
The companion guide on radon poison misframing covers why this terminology persists despite being inaccurate.
The EPA and Surgeon General framework
EPA classifies radon as a Group A human carcinogen, alongside asbestos, benzene, tobacco smoke, and arsenic. The U.S. Surgeon General has issued formal health advisories on radon (2005, with continuing emphasis). Both agencies frame radon as a long-term lung cancer risk, not as a poison.
EPA’s risk estimates: for never-smokers, lifetime lung cancer risk at the 4.0 pCi/L action level is approximately 7 per 1,000; at 20 pCi/L it is approximately 36 per 1,000. For smokers, the risks are an order of magnitude higher: 62 per 1,000 at 4.0 pCi/L and 260 per 1,000 at 20 pCi/L. These are lifetime risks, accumulated over decades of exposure.
What does appear — eventually
Radon-attributable lung cancer presents identically to other lung cancers: persistent cough that does not resolve, coughing blood, chest pain, recurring respiratory infections (bronchitis, pneumonia), shortness of breath, wheezing, hoarseness, unexplained weight loss, and fatigue. These symptoms typically appear after years to decades of cumulative exposure and represent established disease.
Lung cancer staging at diagnosis ranges from Stage 1 (localized, often surgically treatable) to Stage 4 (metastatic). Earlier-stage diagnosis has better outcomes. This is why screening matters for high-risk populations and why prevention through radon testing and mitigation is preferred over post-disease intervention.
The dose-response relationship
Radon risk scales with the product of concentration and time. Health physicists express cumulative exposure in working-level-months (WLM). One WLM represents one working level of decay-product exposure for 170 hours. Residential exposure at 4.0 pCi/L produces approximately 0.4 WLM per year for a full-time occupant.
The published epidemiology from uranium miners — the largest dataset linking radon to lung cancer — shows excess risk above approximately 40 WLM cumulative exposure for non-smokers, with much lower thresholds for smokers. Residential exposure rarely accumulates to miner levels but produces measurable population-level risk at lower cumulative doses because exposure spans decades.
The dose-response is approximately linear at low doses. EPA, CDC, and the National Research Council’s BEIR VI report all use linear no-threshold modeling for radon risk estimation. There is no safe lower threshold below which risk drops to zero, but risk does drop sharply with lower concentrations.
The biological mechanism
Radon-222 decays through a chain of short-lived radioactive isotopes (polonium-218, lead-214, bismuth-214, polonium-214) before reaching stable lead-206. The polonium isotopes are alpha emitters, and alpha radiation has the highest linear energy transfer (LET) of common radiation types — meaning each alpha particle deposits significant ionizing energy in a tiny region of tissue.
Inhaled decay products attached to aerosol particles deposit on bronchial epithelium. Alpha decays from these deposits emit particles that travel only 30 to 70 micrometers — but that distance is enough to reach basal cells where lung carcinogenesis can initiate. Each alpha track produces dense DNA damage that the cell’s repair machinery sometimes fixes incorrectly, producing mutations.
Over years to decades, accumulated mutations in basal lung cells can produce cancerous transformations. The probability per cell per year is very low, but the lungs contain billions of cells and exposure persists chronically. Cancer is a probabilistic outcome at population level, not a deterministic effect at individual level.
When to consult a physician
If you have any current respiratory symptoms — persistent cough, chest pain, shortness of breath, recurring infections — see a physician. These symptoms are not caused by radon directly and have other treatable causes (infection, asthma, allergies, cardiac issues). Delaying medical evaluation while researching radon is not the right tradeoff.
If you have decades of significant radon exposure history (lived 20+ years in a known high-radon home, occupational exposure as a miner) or a 20-pack-year smoking history, discuss lung cancer screening with your primary care physician. The U.S. Preventive Services Task Force recommends annual low-dose CT screening for adults aged 50 to 80 meeting these criteria.
If you have a family history of lung cancer in non-smokers, mention this to your physician — it may indicate elevated genetic susceptibility worth incorporating into screening decisions.
When to test the home
Always. EPA recommends every home be tested regardless of geography, construction age, or occupant smoking status. Short-term test kits ($15 to $50) are available from hardware stores and CDPHE for Colorado residents. Long-term kits ($25 to $75) give better annual averages. Continuous radon monitors used by certified professionals ($150 to $300 service) provide hourly data.
If the test result is above 4.0 pCi/L, mitigate. Active soil depressurization installed by a certified mitigation contractor typically reduces concentrations to below 1.0 pCi/L. Front Range pricing: $1,200 to $2,500. The companion guide on radon mitigation methods covers technical options.
Smoking and radon: the multiplicative risk
The combined risk from smoking and radon exposure is multiplicative, not additive. A smoker exposed to elevated radon faces substantially higher lung cancer risk than the sum of either alone. The Surgeon General and EPA both emphasize this. For households with current or former smokers, mitigation and smoking cessation together produce the largest risk reduction. CDC tobacco cessation resources are available through state quit lines.
The geographic context for Front Range homeowners
Colorado’s Front Range is a high-radon region by geology. The uranium-bearing rock underlying much of the metro corridor produces elevated soil gas radon in many locations. EPA Map of Radon Zones classifies Adams, Arapahoe, Boulder, Broomfield, Denver, Douglas, El Paso, Jefferson, Larimer, and Weld counties as Zone 1 (highest predicted indoor radon potential). CDPHE measurements show approximately half of tested Colorado homes exceed the EPA action level. The probability that a given Front Range home has elevated radon is meaningfully higher than the national average.
That said, geographic risk is statistical. Two homes on the same street can test at 1.5 pCi/L and 15 pCi/L because of foundation differences, soil pathway variability, and HVAC operation. The only way to know about a specific home is to test it. The companion guide on causes of radon in homes covers the geology and entry mechanisms.
What the cumulative-exposure framing implies for action
If risk accumulates with concentration multiplied by time, then both reducing concentration (mitigation) and reducing time-weighted exposure (less basement bedroom use, more ventilation) lower risk. Mitigation by ASD is the most effective single intervention. Lifestyle adjustments are secondary but matter for households with high-radon homes awaiting mitigation. EPA does not consider lifestyle adjustments a substitute for mitigation when concentrations exceed the action level — they are interim measures.
What homeowners should ignore
Common misinformation worth ignoring: house plants that “remove radon” (no plant removes radon at meaningful rates); HEPA air purifiers as standalone radon solutions (they do not remove radon gas, only some attached decay products on aerosols); essential oil or chemical “neutralizers” (no chemical agent neutralizes a noble gas or its radioactive decay); and “radon detoxification” supplements (no supplement removes radon or its effects from the body — radon does not accumulate in the body to begin with).
The Front Range market sometimes sees pseudo-mitigation products marketed to homeowners. EPA-recognized mitigation requires soil-gas redirection (ASD or related), not air filtration or chemical treatment. The American Lung Association corroborates this framework.
What the data on 21,000 annual deaths implies for individual choice
The 21,000 figure is a U.S. population-level estimate. For an individual living in a 4.0 pCi/L home as a non-smoker, lifetime lung cancer risk attributable to radon is approximately 0.7 percent (7 per 1,000). At 20 pCi/L, that rises to approximately 3.6 percent (36 per 1,000). Mitigation reduces those numbers proportionally. The decision to test and mitigate is essentially a small expenditure (a few hundred dollars for testing, a few thousand for mitigation) to substantially reduce a real long-term risk.
How clinicians actually approach radon in practice
Primary care physicians do not “test patients for radon” — there is no test to run. When a patient mentions radon exposure history, the clinician typically incorporates that into the broader lung cancer risk discussion alongside smoking history, family history, occupational exposures, and prior chest imaging findings. If cumulative exposure is significant and other risk factors are present, the clinician may recommend lung cancer screening per USPSTF guidelines. The intervention is at the home level (test and mitigate), not the body level.
Why this framing matters for public health communication
Public health communication that frames radon as “poisoning” inadvertently sets up the wrong mental model in homeowners. The wrong model produces wrong actions — checking for symptoms (which do not exist) instead of testing the home (which is the actual intervention). EPA and major health organizations have moved toward “exposure,” “carcinogen,” and “long-term risk” terminology specifically because the mechanical framing of poisoning does not match the radiological reality. The companion guide on radon sickness terminology covers this terminology gap.
Testing options summarized
Short-term mail-in kits: $15 to $50, 2 to 7 days, suitable for initial screening. Long-term mail-in kits: $25 to $75, 90+ days, better annual average. Continuous radon monitors (professional service): $150 to $300, 48 to 96 hours, used in real estate transactions and for confirmation. CDPHE discount kits: ~$15, mailed to Colorado residents. Hardware store kits: $20 to $50, brands include AccuStar, AirChek, RadonAway, and Pro-Lab. Any of these are valid for the first screening; choose based on convenience and timing.
How a homeowner explains radon to family members
Plain-language framing that works: “Radon is a natural radioactive gas that comes out of the ground. It can build up indoors and, over many years, increases lung cancer risk. There are no immediate symptoms — you cannot tell by how you feel. We’re going to test, and if the level is too high, we’ll install a fan-and-pipe system that vents it out above the roof. The test costs about $20 and the system costs $1,500 to $2,500.” Five sentences cover the topic without poisoning-framing or alarmism.
References
- EPA Health Risk of Radon — U.S. Environmental Protection Agency
- CDC Radon page — Centers for Disease Control and Prevention
- NIEHS Radon information — National Institute of Environmental Health Sciences
- American Lung Association on radon — American Lung Association
- CDPHE radon program — Colorado Department of Public Health and Environment
If you are on the Front Range and want to connect with a certified radon measurement or mitigation professional, you can reach out through our contact page.